Team develops gene circuit design strategy to advance synthetic biology – Gears Of Biz
Gears Of Biz |
Team develops gene circuit design strategy to advance synthetic biology
Gears Of Biz “With the increase of circuit complexity, the lack of predictive design guidelines has become a major challenge in realizing the potential of synthetic biology,” said Lu, who also is affiliated with the Carl R. Woese Institute for Genomic Biology and … |
|
OC woman to get life-saving stem cell transplant from sister after US gov’t grants temp stay
KABC-TV An Orange County woman who was on the brink of death and denied her sister’s life-saving stem cells by the U.S. government will now be able to receive the treatment. (KABC). KABC. By David Ono. Wednesday, September 27, 2017 07:29PM. IRVINE, Calif. |
Davis Enterprise |
UCD ‘Biomaker Lab’ helps scientists, engineers explore solutions
Davis Enterprise It has facilitated various student design projects ranging from new chemical face peels to bio-based glues to novel blood separation devices, and catalyzed the formation of two new project-based courses, one in synthetic biology and one in protein … |
Myeloma Research News |
Autolus Advances New Myeloma CAR T-cell Therapy in Clinical Trial
Myeloma Research News Autolus has successfully completed dosing the first group of patients in a Phase 1/2 trial of AUTO2 — a CAR T-cell therapy that targets two factors that drive disease in patients with relapsed or refractory multiple myeloma. Researchers believe that … |
GeekWire |
Seattle Children’s licenses gene-editing therapy to Casebia Therapeutics and will partner on further research
GeekWire The tech is based on work by Dr. David Rawlings, who leads Seattle Children’s Center for Immunity and Immunotherapies, and Dr. Andrew Scharenberg, who co-led the Program in Cell and Gene Therapy before joining Casebia as its chief scientific officer. |
ABP LIVE |
Intravenous Umbilical Cord Stem Cell Tx Assessed in HFrEF Patients
Monthly Prescribing Reference (registration) HealthDay News — Intravenous infusion of umbilical cord-derived mesenchymal stem cells (UC-MSCs) is safe and efficacious for patients with heart failure and reduced ejection fraction (HFrEF), according to a study published online September 26 in … Umbilical Cord-Derived Stem Cells Could Help Those with Heart FailureTechnology Networks Can Babies Help Heart Patients?Philly.com |